Allergic Rhinitis Management: a Delphi Consensus Promoted by the Italian Society of Pediatric Allergy and Immunology (SIAIP)

Overview

Journal Ital J Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2024 Nov 29

PMID 39609911

Authors

Michele Miraglia Del Giudice

Gian Luigi Marseglia

Diego G Peroni

Anna Maria Zicari

Giulio Dinardo

Giorgio Ciprandi

Affiliations

Soon will be listed here.

Abstract

Allergic rhinitis (AR) is the most frequent IgE-mediated disease, mainly in children and adolescents. Management of AR in the pediatric age may be heterogeneous, and the available guidelines do not adequately consider this issue. As a result, the Italian Society of Pediatric Allergy and Immunology (SIAIP) promoted a Delphi Consensus to define and evaluate the most relevant aspects of AR management in the pediatric setting in Italy. A qualified board of experts prepared a list of statements that a panel of Italian experts voted on using a web platform. Forty-two pediatricians participated. The results showed that all statements had consensus (> 80% of scores 4 + 5). In particular, there was awareness that AR is a type 2 inflammatory disease requiring adequate treatment. Topical drugs should be preferred, as they are better with cycles. Combined antihistamine/corticosteroid is also considered effective and safe in adolescents. In conclusion, AR deserves adequate attention and care. Current medications are safe and effective; treatment should be addressed to dampen type 2 inflammation and relieve complaints.

References

Wise S, Damask C, Greenhawt M, Oppenheimer J, Roland L, Shaker M . A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023. J Allergy Clin Immunol Pract. 2023; 11(3):773-796. DOI: 10.1016/j.jaip.2023.01.007. View

Bousquet J, Anto J, Bachert C, Baiardini I, Bosnic-Anticevich S, Canonica G . Allergic rhinitis. Nat Rev Dis Primers. 2020; 6(1):95. DOI: 10.1038/s41572-020-00227-0. View

Passali D, Passali G, Damiani V, Ciprandi G . Azelastine/fluticasone and allergic rhinitis in clinical practice. Eur Arch Otorhinolaryngol. 2023; 280(10):4713-4714. DOI: 10.1007/s00405-023-08006-9. View

Berger W, Meltzer E, Amar N, Fox A, Just J, Muraro A . Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment. Pediatr Allergy Immunol. 2016; 27(2):126-33. DOI: 10.1111/pai.12540. View

Cohen B . Allergic Rhinitis. Pediatr Rev. 2023; 44(10):537-550. DOI: 10.1542/pir.2022-005618. View

Ciprandi G . Budenoside aqueous nasal spray: an updated reappraisal in rhinitis management. Minerva Med. 2024; 115(2):203-213. DOI: 10.23736/S0026-4806.24.09214-0. View

Scadding G, Kariyawasam H, Scadding G, Mirakian R, Buckley R, Dixon T . BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clin Exp Allergy. 2018; 47(7):856-889. DOI: 10.1111/cea.12953. View

Chipps B, Harder J . Antihistamine treatment for allergic rhinitis: different routes, different outcomes?. Allergy Asthma Proc. 2009; 30(6):589-94. DOI: 10.2500/aap.2009.30.3287. View

Bousquet J, Meltzer E, Couroux P, Koltun A, Kopietz F, Munzel U . Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. J Allergy Clin Immunol Pract. 2018; 6(5):1726-1732.e6. DOI: 10.1016/j.jaip.2018.01.031. View

10.

Zicari A, Indinnimeo L, De Castro G, Incorvaia C, Frati F, Dellalbani I . A survey on features of allergic rhinitis in children. Curr Med Res Opin. 2013; 29(5):415-20. DOI: 10.1185/03007995.2013.779238. View

11.

Conti D, Vibeke B, Kirsten B, Leif B, Adam C, Stephanie D . EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus. Pediatr Allergy Immunol. 2024; 35(7):e14183. DOI: 10.1111/pai.14183. View

12.

Czech E, Overholser A, Schultz P . Allergic Rhinitis. Prim Care. 2023; 50(2):159-178. DOI: 10.1016/j.pop.2023.01.003. View

13.

Tosca M, Trincianti C, Naso M, Nosratian V, Ciprandi G . Treatment of Allergic Rhinitis in Clinical Practice. Curr Pediatr Rev. 2023; 20(3):271-277. DOI: 10.2174/1573396320666230912103108. View

14.

Brozek J, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S . Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017; 140(4):950-958. DOI: 10.1016/j.jaci.2017.03.050. View

15.

Xu Z, Wu Y, Tai J, Feng G, Ge W, Zheng L . Risk factors of obstructive sleep apnea syndrome in children. J Otolaryngol Head Neck Surg. 2020; 49(1):11. PMC: 7057627. DOI: 10.1186/s40463-020-0404-1. View

16.

Sousa-Pinto B, Vieira R, Brozek J, Cardoso-Fernandes A, Lourenco-Silva N, Ferreira-da-Silva R . Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis. J Allergy Clin Immunol. 2024; 154(2):340-354. DOI: 10.1016/j.jaci.2024.04.016. View

17.

Licari A, Magri P, De Silvestri A, Giannetti A, Indolfi C, Mori F . Epidemiology of Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pract. 2023; 11(8):2547-2556. DOI: 10.1016/j.jaip.2023.05.016. View

18.

Jones J, Hunter D . Consensus methods for medical and health services research. BMJ. 1995; 311(7001):376-80. PMC: 2550437. DOI: 10.1136/bmj.311.7001.376. View

19.

Ciprandi G . [Recent advances in the practical management of allergic rhinitis.]. Recenti Prog Med. 2024; 115(4):1-10. DOI: 10.1701/4264.42413. View

20.

Sousa-Pinto B, Schunemann H, Sa-Sousa A, Vieira R, Amaral R, Anto J . Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference. Allergy. 2022; 77(10):3002-3014. DOI: 10.1111/all.15371. View